Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13
Year: 2021
Type: article
Study design: Observational Study
Abstract: We found that with the incorporation of the PCV13 vaccine, the numbers of IPD cases caused by serotypes included in this vaccine decreased in all of the age groups. Still, there was an unforeseen increase of the serotypes not included in this vaccine causing IPD, especially in the >65-year-old group. Moreover, a significant increase of serotype 3 included in the vaccine has been observed; this event has been reported by other researchers. These facts call for the incorporation of more serotypes in future vaccines and a more thorough surveillance of the dynamics of this microorganism.
Source: Microbiology Spectrum
Authors: A. Redin, P. Ciruela, M. F. de Sevilla, F. Gomez-Bertomeu, S. Gonzalez-Peris, M. A. Benitez, G. Trujillo, A. Diaz, E. Jou, C. Izquierdo, M. O. Perez-Moreno, F. Moraga-Llop, M. Olsina, B. Vinado, E. Sanfeliu, A. Garcia, S. Gonzalez-di Lauro, J. J. Garcia-Garcia, A. Dominguez, R. Sa-Leao, C. Muñoz-Almagro
Institutions: Hospital Sant Joan de Déu Barcelona, Universitat Internacional de Catalunya, Institut de Recerca Sant Joan de Déu, Generalitat de Catalunya, Instituto de Salud Carlos III, Agència de Salut Pública de Catalunya, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, Hospital Universitari Joan XXIII de Tarragona, Vall d'Hebron Hospital Universitari, Althaia, Hospital de Nens de Barcelona, Hospital Universitari de Tortosa Verge de la Cinta, Hospital General de Catalunya, Fundació Hospital d'Olot i Comarcal de la Garrotxa, Hospital Universitari d'Igualada, Hospital de Sant Joan Despí Moisès Broggi, Universitat de Barcelona
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,500
Awards: Evolución de la enfermedad neumocócica invasiva pediátrica tras la introducción de la vacuna conjugada antineumocócica tridecavalente en el calendario sistemático, Tecnologías NGS para la Vigilancia Epidemiológica Molecular de S.pneumoniae y para determinar su invasividad. Quo vadis y Quo invades pneumococcus?
OpenAlex ID: W4200359447